Doxapram
Back to searchMolecule Structure
Scientific Name
Doxapram
Description of the Drug
Doxapram is a short acting respiratory stimulant used to treat acute respiratory insufficiency in COPD patients.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00561
http://www.drugbank.ca/drugs/DB00561
Brand Name(s)
Not Available
Company Owner(s)
Chartwell Injectables Llc, Watson Laboratories Inc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Potassium channel subfamily K member 3 | SINGLE PROTEIN | BLOCKER | CHEMBL2321613 |
| Potassium channel subfamily K member 9 | SINGLE PROTEIN | BLOCKER | CHEMBL2321614 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL644504 | ||
| PharmGKB | PA164784026 | ||
| Human Metabolome Database | HMDB0014701 | ||
| DrugBank | DB00561 | ||
| PubChem: Thomson Pharma | 15078242 | ||
| PubChem | 3156 | ||
| Mcule | MCULE-9853713128 | ||
| LINCS | LSM-5058 | ||
| Nikkaji | J5.501H | ||
| BindingDB | 50505297 | ||
| EPA CompTox Dashboard | DTXSID2022963 | ||
| DrugCentral | 953 | ||
| ChemicalBook | CB4245654 | ||
| Guide to Pharmacology | 7169 | ||
| rxnorm | DOPRAM | DOXAPRAM HYDROCHLORIDE | DOXAPRAM |
| ChEBI | 681848 |
